These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5317371)

  • 21. Diffusion of progesterone through intrauterine silastic rubber implants.
    Gibor Y; Seshadri B; Scommegna A
    Fertil Steril; 1971 Oct; 22(10):671-6. PubMed ID: 5115105
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of micro quantities of 17alpha-hydroxy progesterone caproate released from subcutaneous silastic capsules on the genital organs, spermatozoa & fertility of male rats.
    Das RP; Kumari GL; Roy S
    Indian J Exp Biol; 1977 Nov; 15(11):966-9. PubMed ID: 614193
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the interactions of ethynyl oestradiol and norgestrel.
    Edgren RA; Jones RC; Peterson DL; Gillen AL
    Acta Endocrinol (Copenh); 1967; 54():Suppl 115:3-21. PubMed ID: 6071573
    [No Abstract]   [Full Text] [Related]  

  • 24. Intranasal administration of progesterone increases dopaminergic activity in amygdala and neostriatum of male rats.
    de Souza Silva MA; Topic B; Huston JP; Mattern C
    Neuroscience; 2008 Nov; 157(1):196-203. PubMed ID: 18824215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenteral administration of progestins for hormonal replacement therapy.
    Nath A; Sitruk-Ware R
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):88-96. PubMed ID: 19340703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Principles and evolution of progestational treatment methods of contraception].
    Sitruk-Ware R
    Rev Prat; 1987 Sep; 37(38):2315-21. PubMed ID: 3659797
    [No Abstract]   [Full Text] [Related]  

  • 27. Sustained release hormonal preparations. 9. Plasma levels and accumulation into various tissues of 6-methyl-17 alpha-acetoxy-4,6-pregnadiene-3,20-dione after oral administration or absorption from polydimethylsiloxane implants.
    Kincl FA; Angee I; Chang CC; Rudel HW
    Acta Endocrinol (Copenh); 1970 Jul; 64(3):508-18. PubMed ID: 4916445
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-acting progestogens.
    Affandi B
    Best Pract Res Clin Obstet Gynaecol; 2002 Apr; 16(2):169-79. PubMed ID: 12041960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary and hypothalamic action of progestagens in castrated female rats.
    Bieglmayer C; Spona J; Schroeder R
    Endocrinol Exp; 1980 Mar; 14(1):17-25. PubMed ID: 6772424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled release of testosterone using silicone rubber.
    Shippy RL; Hwang ST; Bunge RG
    J Biomed Mater Res; 1973 Jan; 7(1):95-110. PubMed ID: 4691161
    [No Abstract]   [Full Text] [Related]  

  • 31. Steroid releasing vaginal rings.
    Nuttal ID; Elstein M
    Acta Eur Fertil; 1980 Sep; 11(3):225-30. PubMed ID: 6781195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiological changes associated with sustained delivery of estrogen and estrogen plus progesterone by TCPL devices.
    Cason Z; Tucci M; England B; Benghuzzi H
    Biomed Sci Instrum; 1997; 34():24-9. PubMed ID: 9603007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous steroid treatment by subdermal polysiloxane implants.
    Benagiano G; Ermini M
    Acta Eur Fertil; 1972 Jun; 3(2):119-30. PubMed ID: 4606384
    [No Abstract]   [Full Text] [Related]  

  • 34. Injectable depot contraceptives on d-norgestrel basis. II. Clinical pharmacokinetic studies with d-norgestrel undecylate in women.
    Spona J; Weiner E; Nieuweboer B; Hümpel M; Schneider WH; Johansson ED
    Contraception; 1977 Apr; 15(4):413-28. PubMed ID: 880817
    [No Abstract]   [Full Text] [Related]  

  • 35. Ring-d-bridged steroid analogs. II. 14-alpha, 17-alpha-etheno-16-alpha-carbomethoxypregn-4-ene-3, 20-dione.
    Solo AJ; Singh B
    J Med Chem; 1966 Mar; 9(2):179-81. PubMed ID: 5916499
    [No Abstract]   [Full Text] [Related]  

  • 36. Release of progesterone from silicone rubber implants in vitro, and the effects of the implants on plasma progesterone levels in sheep.
    Cunningham NF; Saba N; Millar PG
    J Reprod Fertil; 1975 Jun; 43(3):555-8. PubMed ID: 1142343
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action of anabolic steroids on the development of the genital system of the rabbit. 3. Influence of 13-beta-ethyl-17-beta-hydroxy-17-alpha-ethyl-4-gonen-3-one on the estrus cycle of the rat].
    Vertechy G; Bertolini A
    Boll Soc Ital Biol Sper; 1968 Jun; 44(11):948-51. PubMed ID: 5693842
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro-in vivo correlation on the subcutaneous release of progestins from silicone capsules.
    Chien YW
    Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1471-9. PubMed ID: 975419
    [No Abstract]   [Full Text] [Related]  

  • 39. Progestins in HRT: sufferance or desire?
    Skouby SO; Jespersen J
    Maturitas; 2009 Apr; 62(4):371-5. PubMed ID: 19203850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aliphatic esters of 6,6-difluoro-17 -hydroxy-17-ethynyl-4-estren-3-one (6,6-difluoronorethindrone) and (+)-6,6-difluoro-13 -ethyl-17 -hydroxy-17-ethynyl-4-gonen-3-one ((+)-6,6-difluoronorgestrel).
    Johnson AL
    Steroids; 1972 Sep; 20(3):263-7. PubMed ID: 5073576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.